These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 336393)

  • 1. Isolation and characterization of a mocimycin resistant mutant of Escherichia coli with an altered elongation factor EF-Tu.
    van de Klundert JA; den Turk E; Borman AH; van der Meide PH; Bosch L
    FEBS Lett; 1977 Sep; 81(2):303-7. PubMed ID: 336393
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutants of Escherichia coli altered in both genes coding for the elongation factor Tu.
    Van de Klundert JA; Van der Meide PH; Van de Putte P; Bosch L
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4470-3. PubMed ID: 360222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elongation factor Tu resistant to kirromycin in an Escherichia coli mutant altered in both tuf genes.
    Fischer E; Wolf H; Hantke K; Parmeggiani A
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4341-5. PubMed ID: 337296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The isolation and mapping of EF-Tu mutations in Salmonella typhimurium.
    Hughes D
    Mol Gen Genet; 1986 Jan; 202(1):108-11. PubMed ID: 3515126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitution of Arg230 and Arg233 in Escherichia coli elongation factor Tu strongly enhances its pulvomycin resistance.
    Boon K; Krab I; Parmeggiani A; Bosch L; Kraal B
    Eur J Biochem; 1995 Feb; 227(3):816-22. PubMed ID: 7867642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin.
    Landini P; Bandera M; Goldstein BP; Ripamonti F; Soffientini A; Islam K; Denaro M
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):649-52. PubMed ID: 1590753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a kirromycin-resistant elongation factor Tu from Escherichia coli.
    Ivell R; Fasano O; Crechet JB; Parmeggiani A
    Biochemistry; 1981 Mar; 20(5):1355-61. PubMed ID: 7013793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kirromycin resistant elongation factor EF-Tu from Escherichia coli contains a threonine instead of an alanine residue in position 375.
    Duisterwinkel FJ; de Graaf JM; Kraal B; Bosch L
    FEBS Lett; 1981 Aug; 131(1):89-93. PubMed ID: 6793402
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired in vitro kinetics of EF-Tu mutant Aa.
    Tapio S; Bilgin N; Ehrenberg M
    Eur J Biochem; 1990 Mar; 188(2):347-54. PubMed ID: 2180702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered regulation of the guanosine 5'-triphosphate activity in a kirromycin-resistant elongation factor Tu.
    Fasano O; Parmeggiani A
    Biochemistry; 1981 Mar; 20(5):1361-6. PubMed ID: 6112013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes.
    Zuurmond AM; Martien de Graaf J; Olsthoorn-Tieleman LN; van Duyl BY; Mörhle VG; Jurnak F; Mesters JR; Hilgenfeld R; Kraal B
    J Mol Biol; 2000 Dec; 304(5):995-1005. PubMed ID: 11124042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appearance of elongation factor Tu in the outer membrane of sucrose-dependent spectinomycin-resistant mutants of Escherichia coli.
    Dombou M; Bhide SV; Mizushima S
    Eur J Biochem; 1981 Jan; 113(2):397-403. PubMed ID: 6451426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Escherichia coli mutant with an altered elongation factor Tu.
    Lupker JH; Verschoor GJ; de Rooij FW; Rörsch A; Bosch L
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):460-3. PubMed ID: 4592692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and biochemical characterization of kirromycin resistance mutations in Bacillus subtilis.
    Smith I; Paress P
    J Bacteriol; 1978 Sep; 135(3):1107-17. PubMed ID: 99428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the inhibition of protein synthesis by kirromycin. Role of elongation factor Tu and ribosomes.
    Wolf H; Chinali G; Parmeggiani A
    Eur J Biochem; 1977 May; 75(1):67-75. PubMed ID: 324765
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism of action of the new antibiotic kirromycin].
    Sander G
    Reprod Nutr Dev (1980); 1981; 21(2):185-92. PubMed ID: 6130579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elongation factor Tu isolated from Escherichia coli mutants altered in TufA and tufB.
    Van der Meide PH; Borman TH; Van Kimmenade AM; Van de Putte P; Bosch L
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3922-6. PubMed ID: 7001448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A third kasugamycin resistance locus, ksgC, affecting ribosomal protein S2 in Escherichia coli K-12.
    Yoshikawa M; Okuyama A; Tanaka N
    J Bacteriol; 1975 May; 122(2):796-7. PubMed ID: 1092672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant ribosomes can generate dominant kirromycin resistance.
    Tubulekas I; Buckingham RH; Hughes D
    J Bacteriol; 1991 Jun; 173(12):3635-43. PubMed ID: 2050625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic studies of the ribosomal proteins in Escherichia. coli. II. Altered 30s ribosomal protein component specific to spectinomycin resistant mutants.
    Dekio S; Takata R
    Mol Gen Genet; 1969; 105(3):219-24. PubMed ID: 4904980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.